ATTD-Asia 2025 Resource Hub  – 

Welcome to our resource hub for ATTD-Asia 2025! This is a one-stop-shop for all your ATTD-Asia 2025 needs. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.

Important Conference Information. ATTD-Asia 2025 is being held at the Suntec Singapore Convention Centre. No virtual attendance option is available.

  1. Conference Website
  2. Conference Registration
  3. Day-by-Day Conference Preview
  4. Conference Program

Day-of Conference Reports

  1. ATTD-Asia 2025 Day #1 Highlights
  2. ATTD-Asia 2025 Day #2 Highlights
  3. ATTD-Asia 2025 Day #3 Highlights

Diabetes Technology Highlights

  1. The case for continuous ketone monitoring: Profs. Thomas Danne and David O’Neal debate the diabetes ecosystem’s preparedness for this technology
  2. Medtronic School: How predictive automation, optimal settings, and flexible strategies drive glycemic outcomes
  3. Medtronic School: AID across all ages: MiniMed 780G for children, adolescents, and the elderly
  4. Medtronic School: AID for pregnancy and T2D; expanding uses and population-wide health
  5. Abbott School: Dr. Satish Garg on the dual opportunity with CGM and GLP-1 RAs to optimize T1D and T2D management
  6. Abbott School: Tips for translating glycemic data into actionable tasks
  7. Abbott School: Panelists share visions of a future endocrinology clinic including AI, telehealth, precision medicine, and pharmacotherapy
  8. Key opportunities to reshape the state of AID in Southeast Asia
  9. Real-world AID use in pregnancy demonstrates strong glycemic outcomes during the third trimester and when using pregnancy-specific algorithms
  10. Dual glucose-ketone monitoring for earlier DKA detection and safer insulin therapy
  11. Dexcom School: CGM as a champion in the battle against elevated glucose levels
  12. Real-world use of MiniMed 780G in Japan and APAC: Insights on glycemic outcomes and user behaviors from Prof. O’Neal and Dr. Noriko Kodani
  13. Glycemic rhythms and heart health: Prof. Ramzi Ajjan on using CGM to meaningfully reshape cardiovascular risk assessment
  14. Benefits and practical challenges to the implementation of inpatient CGM from Prof. Spiros Fourlanos
  15. AI, wearables, and gut health for prediabetes prevention from Prof. Elaine Chow
  16. Preliminary data presented by Prof. Elizabeth Davis shows early AID onboarding improves glycemic outcomes in Australian pediatric T1D
  17. MiniMed 780G found to be cost effective for Japanese adults with T1D compared to MDI with CGM
  18. Full 26-week RADIANT trial results show sustained glycemic improvements with Omnipod 5 and FreeStyle Libre 2
  19. Real-world analysis identifies five optimal Omnipod 5 settings associated with improved glycemic outcomes
  20. MiniMed 780G delivers additional long-term health and economic benefits in Hong Kong and Australian adults with T1D
  21. Understanding bolus patterns as a key determinant of Omnipod 5 outcomes
  22. Prof. Benjamin Wheeler on AID for those that need it the most
  23. Early insights into ketone patterns in T1D using continuous monitoring
  24. The state of diabetes technology in Japan: CGM growth and AID challenges
  25. Dr. Tom Wilkinson presents feasibility results of the second-generation Tandem Freedom FCL algorithm (n=10) in a three-day hotel setting

Diabetes Therapy Highlights

  1. Dr. Jothydev Kesavadev on MASLD/MASH pathophysiology, screening, and management
  2. Beyond AID and CGM: Dr. Viral Shah reviews the evidence for GLP-1 RAs in T1D
  3. Dr. Manoj Chawla reviews disease-modifying therapies for pre-T2D
  4. Toward a functional cure for T1D: Prof. Thomas Danne on TITR, T1D “remission”, and cell replacement therapies

Diabetes Big Picture Highlights

  1. Opening session: Prof. Juliana Chan on OGTT and CGM in redefining prediabetes and diabetes
  2. Early gestational diabetes (eGDM) emerges as a distinct entity, prompting work to establish a global consensus
  3. Dr. Viral Shah introduces novel metric, CGM Dynamic Index, for diagnosing early dysglycemia
  4. Teasing out the relationships between TITR, glycemic variability, and diabetes complications with Prof. Ramzi Ajjan
  5. Pathophysiology and interventions for prediabetes in multiple countries throughout Asian from Dr. Anoop Misra
  6. Dr. Viswanathan Mohan on the potential for charitable organizations to change the course of T1D in low- and middle-income countries
  7. Prof. Catarina Limbert on ISPAD’s Declaration of Lisbon 2024: An imperative for action for childhood diabetes
  8. Updates on T1D screening and monitoring: Screening in Japan and early-stage clinical service in Australia
  9. Increasing rates of GDM are associated with higher maternal age and obesity

Previous ATTD-Asia Coverage on CCKB

ATTD-Asia 2025 Resource Hub -
Top